Purpose The objective of this randomised phase II study was to evaluate the impact in terms
of response and toxicities of induction or consolidation chemotherapy respectively before or …

Purpose A phase III randomised trial was conducted in patients with non-metastatic
unresectable non-small-cell lung cancer in order to compare, in responders to induction …

Introduction We report the long term and overall results of a triplet induction chemotherapy
regimen followed by standard radiotherapy in patients with locally advanced inoperable …

Objectives To assess if induction radiochemotherapy followed by consolidation
chemotherapy (arm A) will improve survival in comparison with the same chemotherapy …

Purpose The aim of this study was to examine whether, after preceding induction
chemotherapy, simultaneous chemoradiotherapy is superior to radiotherapy alone. Patients …

As concomitant chemoradiotherapy for stage III NSCLC is associated with survival
advantage in comparison to a sequential approach, we conducted a phase III randomised …

Background: We conducted a prospective randomized phase III trial comparing induction
chemotherapy followed by concurrent chemoradiotherapy (CCRT) versus immediate CCRT …

Background: Neither the optimal sequence of treatment nor the best combination CT is yet
well-defined in p receiving concomitant therapy. Methods: P with unresectable stage III …

Over the last two decades, several approaches to multimodality therapy have been
investigated in patients with advanced unresectable non–small cell lung cancer. These …

The optimal schedule and regimen of chemotherapy (CT) in association with
chemoradiation has not been established in stage III non-small-cell lung cancer (NSCLC) …